New Frontiers in Pathology is a unique educational event intended to meet the ongoing educational needs of practicing pathologists. Continuous medical education (CME) is required for maintenance of licensure by virtually all state licensing bodies. Satisfying CME requirements hinges on earning a minimum number of American Medical Association Physician Recognition Award category 1 credits through various activities, including courses like New Frontiers in Pathology that are accredited by the Accreditation Council for Continuing Medical Education. Self-assessment modules (SAMs) are a key component of the American Board of Pathology expectations for maintenance of board certification. Beginning in 2006, the American Board of Pathology granted only time-limited certificates as part of an American Board of Medical Specialties-wide process for maintenance of board certification. Maintenance of board certification has requirements in 4 categories: professional standing, life-long learning and self-assessment, cognitive expertise, and evaluation of performance in practice. Life-long learning and self-assessment includes not only the traditional elements of CME but also the SAMs that are defined as educational products comprising self-administered examinations with a predetermined minimum performance level and a mechanism for receiving feedback. New Frontiers in Pathology will offer SAMs, in addition to the American Medical Association Physician Recognition Award category 1 credits, which it has been accredited to do since its inception, at its 2012 conference scheduled for August 3 through August 5 at The Homestead Resort, Michigan's largest waterfront resort on beautiful Lake Michigan.
(Arch Pathol Lab Med. 2012;136:851-853; doi: 10.5858/ arpa.2012-0234-ED) N ew Frontiers in Pathology offers CME credits and SAMs through a unique curriculum that combines 3 plenary and keynote lectures intended to focus on cuttingedge discoveries likely to be of interest to all pathologists, 21 short (20-30 minute) case presentations intended to illustrate practical approaches to diagnostic challenges using modern diagnostic techniques, and breakout sessions that provide a less-formal setting in which to review cases with expert faculty. Enduring materials from these conferences include not only handouts but also online video clips in which audio is synchronized with slide presentations, a resource to which attendees can return when confronted with challenges in the course of daily practice or when educating others.
The ; implications of laboratory discoveries for our understanding of ovarian carcinogenesis 3 ; managing patients with acute myeloid leukemia using modern molecular tools based on a rapidly evolving understanding of molecular diversity 4 ; an integrated clinical, pathologic, and molecular approach to adrenocortical tumors 5 ; and controversies in the diagnosis of Barrett esophagus and related dysplasia. 6 Together with first author Lisa Cerilli, MD, Dr Greenson has contributed a comprehensive review article on differential diagnosis of colitis in endoscopic biopsies 7 in this the latest special section of the ARCHIVES, certain to be an important resource for the thousands of pathologists who confront, on a regular basis, the diagnostic challenges of the sort targeted in New Frontiers in Pathology. Other contributions from University of Michigan faculty and trainees, and guest speaker Philip Cagle, MD, and his coauthor Sergio Pina-Oviedo, MD, draw from case presentations and breakout sessions to review common and uncommon diagnostic problems. The range of topics is certain to include something of interest to most practitioners and includes comprehensive reviews of lymphomas of the gastrointestinal tract, cutaneous lymphomas, diffuse malignant mesotheliomas, clear cell tumors of the central nervous system, various diseases that may secondarily or primarily affect skeletal muscle, metaplastic breast carcinomas, tenosynovial giant cell tumors, a subset of high-grade carcinomas involving the renal sinus, hepatoblastoma, hypersensitivity pneumonia, and mantle cell lymphoma.
Keeping pace with demands for life-long learning and self-assessment in an age of information overload, escalating public expectations, and increasing regulatory oversight is challenging. New Frontiers in Pathology is intended to help by offering a unique opportunity to learn from experts while enjoying the amenities of an idyllic academic setting on the campus of the University of Michigan or a world class resort on the shores of Lake Michigan.
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